Award
National Institute on Drug Abuse 75N95021D00025-0-9999-1
IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES IDIQ CONTRACT. POP 9/27/21-9/26/26. NTE $3.5 MILLION. FIRST TASK ORDER 01 OBLIGATED IN THE AMOUNT O
Recipient
SRI INTERNATIONAL
Award Amount
$89,708.00
Ceiling
$89,708.00
Awarded
September 27, 2021
Identifier
75N95021D00025-0-9999-1
Contract awarded to SRI INTERNATIONAL to conduct in vitro metabolism and in vivo ADME studies supporting NIDA's medication development program, aiding FDA submissions for INDs and NDAs.
Description
The objective of this contract is to carry out in vitro metabolism and permeability and in vivo ADME studies to support the medications development program of the National Institute on Drug Abuse (NIDA). NIDA and NIDA sponsored investigators will use the data obtained for submissions to the Food and Drug Administration (FDA) in support of Investigational New Drugs (INDs) and New Drug Applications (NDAs).